Chronic Multisymptom Illness CMI
Publication Date: May 1, 2021
Last Updated: March 14, 2022
Recommendations
Treatment of CMI
a. Pharmacotherapy
1. We recommend against the long-term use of opioid medications for the management of chronic pain in patients with CMI. (Strong against)
315659
2. We recommend against offering mifepristone for patients with CMI. (Strong against)
315659
b. Behavioral Health
3. We suggest offering cognitive behavioral therapy for CMI and symptoms consistent with fibromyalgia, irritable bowel syndrome, or myalgic encephalomyelitis/chronic fatigue syndrome. (Weak for)
315659
4. We suggest offering mindfulness-based therapies for patients with CMI and symptoms consistent with fibromyalgia, irritable bowel syndrome, or myalgic encephalomyelitis/chronic fatigue syndrome. (Weak for)
315659
5. There is insufficient evidence to recommend for or against the use of biofeedback modalities in patients with CMI and symptoms consistent with fibromyalgia, irritable bowel syndrome, or myalgic encephalomyelitis/chronic fatigue syndrome. ()
315659
c. Complementary and Integrative Health
6. There is insufficient evidence to recommend for or against the use of manual musculoskeletal therapies for patients with CMI and symptoms consistent with fibromyalgia, irritable bowel syndrome, or myalgic encephalomyelitis/chronic fatigue syndrome. ()
315659
Title
Chronic Multisymptom Illness CMI
Authoring Organization
Veterans Health Administration / Department of Defense